Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Incyte Corp INCY

Healthcare Biotechnology
Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is... see more

Recent & Breaking News (NDAQ:INCY)

Apple May Boost Dividend by 56% According to Analysts. Fed Agrees To Continue Quantitative Easing.

PR Newswire March 19, 2013

Free Research Reports on INCY, NBG, WSTL and YRCW Issued by the Bedford Report

Marketwired March 19, 2013

Morning Research on Arena Pharma, Incyte, Galena Biopharma, and Novavax

PR Newswire March 19, 2013

The Real Story Behind LULU, INCY, CBS and ABT

Marketwired March 19, 2013

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and the May 6, 2013 Lead Plaintiff Deadline -- INCY

Troy Schwensen March 18, 2013

Innovative Product Portfolios Ride Commercialization & Global Expansion - Research Report on Amgen, Onyx Pharmaceuticals, Alexion Pharmaceuticals, BioMarin Pharmaceutical and Incyte

PR Newswire March 18, 2013

Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Incyte Corporation

Business Wire March 16, 2013

Incyte Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Possible Breaches of Fiduciary Duty

Business Wire March 14, 2013

Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Incyte Corporation

Business Wire March 13, 2013

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Incyte Corporation

Business Wire March 6, 2013

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

Marketwired February 18, 2013

Free Research Report on Incyte Corp., ONEOK Partners, L.P., MB Financial, Inc., Hatteras Financial Corp. and U.S. Silica Holdings, Inc.

Marketwired February 15, 2013

Incyte Reports 2012 Fourth-Quarter and Full-Year Financial Results; Provides 2013 Financial Guidance; Updates Shareholders on Key Clinical Programs

Business Wire February 14, 2013

Incyte to Report Fourth Quarter/Year-End 2012 Financial Results on February 14

Business Wire January 24, 2013

Our Pros Knew GFA, INCY, ARNA and FBN Would Be Top Gainers on Monday

Marketwired January 15, 2013

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Marketwired January 2, 2013

Should Recent Insider Buying on EXEL, INCY, NPBC and AEL Matter to You?

Marketwired December 21, 2012